1012418

The Procter & Gamble Company — FEI 3000719926

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 10, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mason, OH (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)